Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
about
Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatristsPharmacotherapy of Acute Bipolar Depression in Adults: An Evidence Based ApproachThe Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic ReviewAripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives.An update of safety of clinically used atypical antipsychotics.Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette SyndromeThe effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole.Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch.The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution.Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity.Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic ImplicationsAntipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats.Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes.The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task.Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc.Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion.Behavioral Mechanisms That Depend on Dopamine and Serotonin in Interact With the Antipsychotics Risperidone and AripiprazoleMaking Sense of Pharmacology: Inverse Agonism and Functional Selectivity
P2860
Q26747123-B4844701-22C8-42F5-B244-8600FF84D12EQ26747670-CC993210-1A91-4696-919D-2729BD3ED6F2Q26748677-B95C8C4C-CBF8-4873-9DF5-7846785465B3Q35995252-6380C5AB-0153-466B-B867-2A1D489B0482Q36062184-EF14650E-1DF1-4117-B8AC-4B7CEEB1C884Q37246827-B3E8F11A-1F9F-48D4-B83D-3E807556BE8BQ37649902-6114788F-6F4E-45EE-BAAB-28F4D106EA9CQ38728328-2BAE77FF-1686-4BAC-958B-99DEA2803C90Q38838664-2999263C-3213-4CF0-A621-5C6669D6E4A2Q39070340-74A9B2E2-6ED6-455B-A3F5-D68FB6E61D4FQ39162868-AF60D4E4-11DE-46BA-BDC5-CAB56AFE33EAQ39196169-896C3E1E-A048-4E7A-9F81-108F61DD97B0Q39210357-C86292C3-C187-4904-9B89-8FCFA7C51FEDQ39244947-E23EEE49-0AED-495F-B7B4-AB0DA4E2F794Q39267337-AAC09B26-DC1A-4C6A-A561-1E5AFC17C167Q39396657-48EA6411-F45B-47C6-9D5A-8F9735DB3A44Q46133668-395212F2-48DD-4F6D-8FE1-754397C69144Q47669147-1BFEE88D-0551-48FA-890B-6B0003820480Q47871481-BF75CF42-F726-4365-BB01-6975FF5F092EQ52688732-90F1B880-88B7-4AD0-B458-57525661829AQ55092897-D51FB050-7491-4108-B445-32CF7A7FCE17Q55253133-F03B3CE4-9B50-41B3-A46F-51F6212119CCQ58725753-C614FE1B-0C96-4D25-B5AE-D084DA248494Q58798205-B7E524EE-71D2-49BB-880F-A36F386C7DDE
P2860
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@ast
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@en
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@nl
type
label
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@ast
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@en
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@nl
prefLabel
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@ast
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@en
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@nl
P2093
P2860
P921
P3181
P1433
P1476
Update on the Mechanism of Act ...... d Dopamine Receptor Antagonism
@en
P2093
Andrea de Bartolomeis
Carmine Tomasetti
Felice Iasevoli
P2860
P2888
P304
P3181
P356
10.1007/S40263-015-0278-3
P407
P5008
P577
2015-09-01T00:00:00Z